My opinion is that there is a "fear" of CR to raise the required funds which is capping the share price. Once that is sorted via CR or partnering and with some grants, then the floor should essentially be set, with the science taking over.
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-487
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.015(7.89%) |
Mkt cap ! $99.76M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $129.6K | 653.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 119947 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 119150 | 7 |
View Market Depth
| Last trade - 15.59pm 09/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |